Number of shares and votes in Oncopeptides

LHFI

STOCKHOLM – September 30, 2025 – Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that the number of shares and votes in Oncopeptides has changed as a result of the rights issue which ended on September 15, 2025.

After the rights issue, the total number of shares in Oncopeptides amounts to 272,706,357 shares, of which 258,211,437 are ordinary shares and 14,494,920 are class C shares. After the rights issue, the total number of votes in Oncopeptides amounts to 259,660,929. The share capital has increased by SEK 5,216,392.878513 from SEK 25,084,314.685381 to SEK 30,300,707.563894.

Datum 2025-09-30, kl 10:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!